Halo Pharmaceutical Revenue and Competitors

East Rutherford, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Halo Pharmaceutical's estimated annual revenue is currently $59.3M per year.(i)
  • Halo Pharmaceutical's estimated revenue per employee is $251,250

Employee Data

  • Halo Pharmaceutical has 236 Employees.(i)
  • Halo Pharmaceutical grew their employee count by 3% last year.

Halo Pharmaceutical's People

NameTitleEmail/Phone
1
Security OfficerReveal Email/Phone
2
Validation ManagerReveal Email/Phone
3
QA ManagerReveal Email/Phone
4
QC ManagerReveal Email/Phone
5
Warehouse ManagerReveal Email/Phone
6
Chef, Supply ChainReveal Email/Phone
7
Analyste micobiologieReveal Email/Phone
8
Spécialiste support technique, laboratoire contrôle qualitéReveal Email/Phone
9
PharmaceuticalReveal Email/Phone
10
Data ReviewerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.6M3332%N/AN/A
#2
$38M1896%N/AN/A
#3
$6.6M3322%N/AN/A
#4
$4180M152421%$550MN/A
#5
$17.5M8750%N/AN/A
#6
$6.7M125-37%$199.6MN/A
#7
$10.9M5415%N/AN/A
#8
$15.3M7633%N/AN/A
#9
$128.6M64016%N/AN/A
#10
$18.7M9321%N/AN/A
Add Company

What Is Halo Pharmaceutical?

Halo Pharmaceutical, headquartered in Whippany, New Jersey contract manufactures product for several clients and is a full service FDA, (both CBER and CDER) and DEA (C2-C5) facility. The manufacturing capabilities cover all aspects of commercial production of small molecule and biological drugs, specializing in solid dosage form manufacturing and finished goods packaging.

keywords:N/A

N/A

Total Funding

236

Number of Employees

$59.3M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Halo Pharmaceutical News

2022-04-13 - Antares Pharma to be acquired by Halozyme in $960M deal ...

The transaction has been unanimously approved by both the Halozyme (NASDAQ: HALO) and Antares boards of directors.

2022-04-13 - Halozyme bolsters drug delivery business with $960 mln ...

April 13 (Reuters) - Halozyme Therapeutics Inc (HALO. ... all-cash deal for specialty pharmaceutical company Antares Pharma Inc (ATRS.

2022-04-13 - Halozyme to Acquire Antares Pharma to Create a Specialty ...

SAN DIEGO and EWING, N.J., April 13, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") and Antares Pharma,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M24369%N/A
#2
$102.8M4557%N/A
#3
$126.8M4618%N/A
#4
$107.7M594N/AN/A
#5
$165.5M7397%N/A